[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$f1pcyym8tp0dj7":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":12,"latestLoe":12,"basis":21,"carveOutPossible":13,"openStrengths":22,"headlineStrengths":22,"headlineFallback":13,"approvalsBeforeLoe":23,"products":24,"patents":49,"exclusivities":50,"paragraphIv":51,"catalysts":53},"AVALIDE","HYDROCHLOROTHIAZIDE; IRBESARTAN","SANOFI AVENTIS US","sanofi-aventis-us",[20],"020758","none",2,0,[25,33,39,44],{"key":26,"applNo":20,"productNo":27,"dosageForm":28,"route":29,"strength":30,"approvalDate":31,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"020758-001","001","TABLET","ORAL","12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","1997-09-30","DISCN",{"key":34,"applNo":20,"productNo":35,"dosageForm":28,"route":29,"strength":36,"approvalDate":31,"rld":4,"teCode":37,"type":38,"loe":12,"basis":21,"carveOutPossible":13},"020758-002","002","12.5MG;150MG","AB","RX",{"key":40,"applNo":20,"productNo":41,"dosageForm":28,"route":29,"strength":42,"approvalDate":43,"rld":4,"teCode":37,"type":38,"loe":12,"basis":21,"carveOutPossible":13},"020758-003","003","12.5MG;300MG","1998-08-31",{"key":45,"applNo":20,"productNo":46,"dosageForm":28,"route":29,"strength":47,"approvalDate":48,"rld":4,"teCode":12,"type":32,"loe":12,"basis":21,"carveOutPossible":13},"020758-004","004","25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","2005-03-15",[],[],{"asOf":12,"firstFiled":12,"entries":52},[],[]]